FDA-RFQ-1226065_QandA_03.doc
DOC document 66 KB Posted
- Attached to
- FDA-RFQ-1226065 Amendment 03 Q&A - Artificial Intelligence Pharmaceutical Imaging Services Federal contract opportunity
- Solicitation number
- FDA-RFQ-1226065
View the file
Other files for this federal contract opportunity
| File | Type | Posted |
|---|---|---|
| FDA-RFQ-1226065_QandA_02.doc | DOC document | |
| FDA-RFQ-1226065_QandA_01.doc | DOC document | |
| FDA-RFQ-1226065Amendment01.doc | DOC document | |
| FDA-RFQ-1226065.doc | DOC document |
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
FDA-RFQ-1226065 Q&A 03
Artificial Intelligence Pharmaceutical Imaging Services
| Document Type: |
| Questions & Answers 03 |
| Solicitation Number: |
| Amendment 03 - FDA-RFQ-1226065 |
| Posted Date: |
| 6 April 2020 |
| Response Date: |
| 15 April 2020 |
| NAICS Code: |
| 541511 - Custom Computer Programming Services, |
Small Size Standard $27.5 million
| Set Aside |
| Total Small Business Set-Aside |
1. Question: Are the 1,000 particle images (taken for each sample) to be used entirely to train the AI/ML modeling, or is it up to Vendor to decide how many quantities of those images should be used to train the AI/ML model and how many should be set aside for performance testing?
Answer: The vendor can decide how many quantities of sample images should be used to train the AI/ML model and how many should be set aside for performance testing.
No further questions will be accepted.
RESPONSE DATE – 15 April RFQ Due Date: All quotes shall be submitted via email to Christine Russman at Christine.Russman@fda.hhs.gov before 2:00 PM Eastern Time on 15 April 2020 .
20 | Page
File details come from the government source that posted it. Updated .